Form 4: BeiGene Director Sells Shares
Insider Transaction (Form 4)
Xiaodong Wang, a Director of BeiGene, Ltd., sold 31,027 shares of common stock on October 13, 2026.
Summary
- Option exercise/conversion: acquired 31,027 American Depositary Shares at $36.90 ($1,144,896) on October 13, 2026; holds 31,027 after (Direct).
- Open-market sale: disposed of 7,167 American Depositary Shares at $349.56 ($2,505,306) on October 13, 2026; holds 23,860 after (Direct).
- Open-market sale: disposed of 10,361 American Depositary Shares at $350.47 ($3,631,262) on October 13, 2026; holds 13,499 after (Direct).
- Open-market sale: disposed of 5,681 American Depositary Shares at $351.40 ($1,996,280) on October 13, 2026; holds 7,818 after (Direct).
- Open-market sale: disposed of 6,558 American Depositary Shares at $352.57 ($2,312,148) on October 13, 2026; holds 1,260 after (Direct).
- Open-market sale: disposed of 1,260 American Depositary Shares at $353.24 ($445,078) on October 13, 2026 (Direct).
- Option exercise/conversion: disposed of 403,351 Share Option (Right to Buy) on October 13, 2026; holds 403,364 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $10,890,074 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Xiaodong Wang — Director, Other (Chair, Scientific Advisory Brd)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-13 | Option exercise/conversion | American Depositary Shares | 31,027 | $37 | $1.1M | 31,027 |
| 2026-10-13 | Open-market sale | American Depositary Shares | 7,167 | $350 | $2.5M | 23,860 |
| 2026-10-13 | Open-market sale | American Depositary Shares | 10,361 | $350 | $3.6M | 13,499 |
| 2026-10-13 | Open-market sale | American Depositary Shares | 5,681 | $351 | $2.0M | 7,818 |
| 2026-10-13 | Open-market sale | American Depositary Shares | 6,558 | $353 | $2.3M | 1,260 |
| 2026-10-13 | Open-market sale | American Depositary Shares | 1,260 | $353 | $445.1K | 0 |
| 2026-10-13 | Option exercise/conversion | Share Option (Right to Buy) | 403,351 | — | — | 403,364 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-13 | Option exercise/conversion (31,027 shares) |
| 2026-10-13 | Open-market sale (7,167 shares) |
| 2026-10-13 | Open-market sale (10,361 shares) |
| 2026-10-13 | Open-market sale (5,681 shares) |
| 2026-10-13 | Open-market sale (6,558 shares) |
| 2026-10-13 | Open-market sale (1,260 shares) |
| 2026-10-13 | Option exercise/conversion (403,351 shares) |
Keywords
insider transaction, Form 4, ONC, BeOne Medicines Ltd., bearish, Xiaodong Wang
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.